Description
Vitrolife is a global biotechnology/medical device Group that works with developing, manufacturing and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue and organs. The company has business activites within three product areas: Fertility, Transplantation and Stem Cell cultivation. Vitrolife today has approximately 150 employees and the company´s products are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and there are subsidiaries outside Gothenburg, Sweden, Denver, USA and in Melbourne, Australia. The Vitrolife share is listed on the OMX Nordic Exchange´s Nordic Small Cap list.
